# Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

> **NCT05855577** · PHASE4 · NOT_YET_RECRUITING · sponsor: **I.R.C.C.S. Fondazione Santa Lucia** · enrollment: 50 (estimated)

## Conditions studied

- Parkinson Disease
- Gait Analysis
- Therapy, Directly Observed
- Metabolic Disease

## Interventions

- **DRUG:** Terazosin

## Key facts

- **NCT ID:** NCT05855577
- **Lead sponsor:** I.R.C.C.S. Fondazione Santa Lucia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-12
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05855577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05855577, "Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05855577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*